IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, H. M.
Right arrow Articles by Holder, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, H. M.
Right arrow Articles by Holder, A. A.

 Previous Article  |  Next Article 

Infection and Immunity, October 2002, p. 5779-5789, Vol. 70, No. 10
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.10.5779-5789.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Variation in the Expression of a Plasmodium falciparum Protein Family Implicated in Erythrocyte Invasion

Helen M. Taylor,* Munira Grainger, and Anthony A. Holder

National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom

Received 1 March 2002/ Returned for modification 20 May 2002/ Accepted 11 June 2002


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The PfRH protein family of Plasmodium falciparum is implicated in erythrocyte invasion. Here we report variations in the sequence, transcription, and protein expression of four different members of this family in three parasite lines, 3D7, T996, and FCB1. There are sequence polymorphisms in PfRH1, PfRH2a, PfRH2b, and PfRH3, ranging from variations across repeat regions to a 585-bp deletion in the 3' end of PfRH2b in T996. Not all the genes are transcribed: although all members of the family are transcribed in 3D7 and T996, PfRH2a and PfRH2b are not transcribed in FCB1. The PfRH1, PfRH2a, and PfRH2b proteins are expressed in late schizonts and merozoites and are located in apical organelles and on the apical surface. However, the PfRH1 protein does not appear to be correctly targeted to the apex in 3D7 and T996. In contrast, the PfRH1 protein is present at the apical end of FCB1 merozoites, but the PfRH2a and PfRH2b proteins are undetectable. The apparent redundancy in the PfRH family of proteins at the level of gene number and sequence and the variations in transcription and protein expression may allow the parasite to use alternative invasion pathways.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
The human malaria parasite Plasmodium falciparum grows and replicates within host red blood cells for part of its life cycle. This erythrocytic stage is responsible for all of the pathology associated with the disease. The invasive merozoite stage of the parasite has a specialized set of apical organelles, the micronemes, rhoptries, and dense granules, whose contents are released at the time of invasion (reviewed in references 6, 11, 12, and 43). Several of the parasite ligands binding to host receptors and involved in invasion are located in the apical organelles. Parasite protein interactions with erythrocytes are thought to mediate a tightly regulated series of steps that lead to the internalization of the parasite within the parasitophorous vacoule. The ligands include, among others, members of the erythrocyte binding protein (EBP) family (1, 9, 29, 51), the apical membrane antigen 1 (AMA-1) family (15, 41), and a superfamily of proteins represented by the P. yoelii 235-kDa rhoptry protein family (Py235) (22, 33, 35) and P. vivax reticulocyte binding proteins (PvRBP) 1 and 2 (16). Recently, genes coding for members of this superfamily were described for P. falciparum (44, 49, 52). Two proteins from this family, referred to here as PfRH2a and PfRH2b (P. falciparum rhoptry protein homolog and reticulocyte binding protein homolog, also known as PfRBP2-Ha and PfRBP2-Hb, respectively), are implicated in P. falciparum invasion of erythrocytes; they appear to be localized to the rhoptries of P. falciparum, and antibodies to these proteins inhibit parasite invasion (44, 52). P. falciparum possesses a third related gene, PfRH3, although this sequence appears to be a transcribed pseudogene in some parasite lines (49).

In this study, we demonstrate variations in the sequence and expression of the PfRH family in laboratory lines of P. falciparum. We characterize an additional member of the family, PfRH1, which is localized to the apical end of merozoites in the FCB1 line but not in the 3D7 and T996 lines. In contrast, the FCB1 line does not express PfRH2a or PfRH2b.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Bioinformatics. TblastN searches of preliminary P. falciparum sequence data at The Institute for Genomic Research, The Sanger Institute, and the Stanford University websites (http://www.tigr.org/, http://www.sanger.ac.uk/, and http://sequence-www.stanford.edu/) and sequence data submitted to EMBL (http://www.ncbi.nlm.nih.gov/Malaria/) were performed by using the translated protein sequences from PfRH2a, PfRH2b, PfRH3, PvRBP, and Py235. Sequence data for P. falciparum chromosome 4 were obtained from The Sanger Institute website (http://www.sanger.ac.uk/Projects/P_falciparum/). Sequencing of P. falciparum chromosome 4 was accomplished as part of the Malaria Genome Project with support from The Wellcome Trust. N-terminal signal sequence, transmembrane domain, hydrophobicity, and topology predictions were performed by using TMHMM and iPSORT (http://www.expasy.ch/). ClustalX was used for alignment of the protein homology regions (50).

Parasite preparation, metabolic labeling, and treatment with brefeldin A (BFA). P. falciparum line 3D7, T996, and FCB1 parasites were cultured in vitro as previously described (7) and used to prepare DNA, RNA, and proteins. For tight synchronization of developmental stages, a combination of sorbitol treatment (27), centrifugation over 70% Percoll (39), and parasite collection with a magnetic separator was used. Large amounts of highly purified schizonts were obtained by an adaptation of the method of Staalsoe et al. (48). Briefly, a MACS type D depletion column was used in conjunction with a SuperMacs II magnetic separator (Miltenyi Biotec). The column was washed with 100% ethanol followed by distilled water and then equilibrated with warm RPMI 1640 plus 2% fetal calf serum (RPMI-FCS) (Invitrogen Life Technologies). P. falciparum-infected erythrocytes were harvested by centrifugation and resuspended in an equal volume of RPMI-FCS. The cell suspension was passed through the column under gravity, and then the column was washed with approximately four column volumes of RPMI-FCS until no erythrocytes were seen in the eluate. The column was removed from the magnet and washed with 50 ml of RPMI-FCS to allow collection of schizonts. Merozoites were prepared as described previously (5).

For collection of parasites throughout an intraerythrocytic developmental cycle, 25 flasks containing 50 ml of a tightly synchronized 3D7 parasite culture (1.4% hematocrit and 10% parasitemia) were gassed and placed at 37°C, and the contents were harvested at 4-h intervals over a 48-h period, beginning with cultures up to 2 h postinvasion. The parasites were pelleted by centrifugation, washed once in phosphate-buffered saline (PBS), and resuspended in TRIZOL (Invitrogen Life Technologies) for RNA preparation. Thin smears for microscopy were made at each time point and stained with Giemsa reagent.

Tightly synchronized late schizonts, estimated to be at 40 to 42 h postinvasion, were radiolabeled by growth in the presence of [35S] methionine and cysteine (Promix; Amersham Pharmacia) (49). Similar schizonts were also labeled in the presence of BFA essentially as described previously (34). Briefly, late schizonts were treated with BFA in methanol (final concentration, 5 µg/ml) or 25 µl of methanol alone and then cultured for 1 h prior to 35S labeling for 1 h as described above in the continuing presence of BFA or methanol (control). To obtain radiolabeled culture supernatants, schizonts at 44 h postinvasion were labeled with [35S]methionine and cysteine for either 4 h or overnight and allowed to release merozoites in the absence of erythrocytes. Culture supernatants were centrifuged at 40,000 rpm in a Beckman TL-100 ultracentrifuge prior to use.

Genotyping of parasite lines with polymorphic markers. DNA from lines 3D7, FCB1, and T996 was typed for the polymorphic loci merozoite surface protein 1 (MSP1) and MSP2 by using PCR primers as described previously (24).

DNA cloning and sequencing and preparation of antisera to recombinant proteins. PCR primers RH1.2f (GGA TCC ATC TAA TTC ATG TTA AGA AAC AAT TTG AAC ACA CC) and RH1.2r (GGA TCC GTG TAG ATA TAT CTT GTT CCT GTA ATT TTG TTG) were used to amplify the region of PfRH1 that contains an apparent frameshift in the database sequence with the proofreading polymerase Pfx (Invitrogen Life Technologies) and genomic DNA derived from lines 3D7, T996, and FCB1 of P. falciparum. The PCR products were sequenced directly by using ABI dRhodamine-terminator cycle sequencing (PE Applied Biosystems).

PCR of the unique regions in PfRH2a and PfRH2b was performed by using primers RH2a.1f (GGA TCC TAA AAA GTA AAC TAG AAT CTG ATA TGG TG) and RH2a.1r (GGA TCC GGT ATT ATC ATC AGT AGT ACT TTC CGA) and primers RH2b.1f (GGA TCC GTA CAC AAA CTA GTC ATA GAA GTA ACA CC) and RH2b.1r (GGA TCC CCA TGT GTT TCC ATA GGT TCA TCA AGT G), respectively. PCR across the repeat regions was performed by using primers RH2repeatF (TAG TAC ATT AAC ACT TGA ATC AAT TCA AAC G) and RH2arepeatR (GTG ATT TCA ATG ATT TCA TCC TTC TCC) or RH2b.1r.

The following primer pairs were used to amplify regions of PfRH1 and PfRH2 for the preparation of recombinant proteins: the homology region of PfRH1 (RH1.1f, GGA TCC TGC AAA ACG AAA TAA GAA ACA TGA ATC TAG; RH1.1r, GGA TCC GTT ATA GTC CTC TTT TAT ATT GTG TAC ATC G), region PfRH1.2 (RH1.2f and RH1.2r), the homology region of PfRH2a and PfRH2b (RH2.HRf, GGA TCC TGA ATG ATG TAT CAA AAT CTG ACC AGA TTG; RH2.HRr, GGA TCC CAC ATC TTC AAT AGT TTT AAT ATA CTG TT), and unique parts of PfRH2a (RH2a.1f and RH2a.1r) and PfRH2b (RH2b.1f and RH2b.1r). The products were cloned into the TA vector (Invitrogen Life Technologies) and subcloned into BamHI-restricted pGEX-3X (Amersham Pharmacia). Glutathione S-transferase (GST) fusion proteins were made and purified on glutathione-agarose (Sigma). The fusion proteins were used to raise antisera in rabbits (RH2.HR and RH2a.1) and BALB/c mice (RH1.1, RH1.2, RH2.HR, RH2a.1, and RH2b.1).

RNA preparation and analysis. RNA was prepared from P. falciparum by using TRIZOL and was analyzed by hybridization of Northern blots as described previously (25, 49). DNA fragments for hybridization were labeled by using a PrimeIt II kit (Stratagene). 5' Rapid amplification of cDNA ends (RACE) (Invitrogen Life Technologies) was carried out with 3D7 schizont-stage RNA by using primers 5race1RH1 (AAC ATC AAA TTT ATA AGA GGA ATC ATT TC) and 5race2RH1 (TAA TAC CGT TTT CTC TTC CTC GAT AGG TC).

Immunoprecipitation of metabolically labeled parasites. Metabolically labeled parasites and culture supernatants were used for immunoprecipitation. Two different extraction methods were used to prepare labeled parasite lysates for immunoprecipitation. In the first protocol, frozen parasite pellets were thawed in 100 µl of sodium dodecyl sulfate (SDS) denaturing buffer (1% SDS, 50 mM Tris-HCl, 5 mM EDTA [pH 8.0]) and boiled for 5 min, and then 900 µl of deoxycholate (DOC) buffer (0.5% sodium deoxycholate, 50 mM Tris-HCl, 5 mM EDTA, 5 mM EGTA) was added. Alternatively, the pellets were thawed in 1 ml of NP-40 buffer (1% Nonidet P-40, 150 mM NaCl, 50 mM Tris-HCl, 5 mM EDTA, 5 mM EGTA [pH 8.0]) containing a complete protease inhibitor mix (Pharmacia). Following antibody addition, the samples were left on ice overnight and then spun at 15,000 rpm and 4°C (Sigma 1K15 centrifuge). Antigen-antibody complexes were precipitated from the supernatants by using protein G-Sepharose for 2 h at 4°C. The beads were washed four times in wash buffer I (50 mM Tris-HCl [pH 8.2], 5 mM EDTA, 0.5% [wt/vol] Triton X-100, 1 mg of bovine serum albumin/ml, 0.5 M NaCl) and four times in wash buffer II (50 mM Tris-HCl [pH 8.2], 5 mM EDTA, 0.5% [wt/vol] Triton X-100) (for SDS-extracted material, the first wash was carried out with wash buffer II). Proteins were resolved with either SDS-polyacrylamide gel electrophoresis (PAGE) (26) or precast NuPAGE gels (Invitrogen Life Technologies).

Western blotting of parasite extracts. Uninfected erythrocytes, tightly synchronized late schizonts (greater than 80% parasitemia), or purified merozoites were lysed directly into sample buffer for SDS-PAGE or NuPAGE. Either 5% polyacrylamide or precast 3 to 8% NuPAGE gradient gels were used. Following electrophoresis, gels were blotted overnight onto Protran nitrocellulose membranes (Schleicher & Schuell). Specific proteins were detected by using polyclonal mouse or rabbit sera followed by horseradish peroxidase-linked secondary antibodies (ICN) and enhanced chemiluminescence (Pierce).

Immunofluorescence assays (IFAs) and microscopy. Smears of P. falciparum-infected red blood cells were fixed with 1% formaldehyde in PBS for 5 min at room temperature. Slides were rinsed in PBS and immersed in blocking buffer (1% bovine serum albumin and 0.1% Triton X-100 in PBS) at 37°C for 30 min in a humid chamber. In addition to the antisera raised to PfRH1, PfRH2a, and PfRH2b, the following were used: rat monoclonal antibody [MAb] 4G2dc1 to AMA-1 (23) (a gift from Alan Thomas), polyclonal rabbit antiserum to EBA-175 (MR4 reagent MRA-2) and rat antiserum to EBA-175 (MR4 reagent MRA-15) (gifts from John Adams), and polyclonal rabbit serum to RhopH2 (19). All antisera were diluted in blocking buffer. Slides were incubated with primary antibodies for 30 min, followed by two 5-min washes in PBS. They were then incubated with fluoroscein isothiocyanate isomer (FITC)-, tetramethylrhodamine isothiocyanate (TRITC)-, or Texas red-conjugated secondary antibodies (Sigma) for 30 min. Slides were washed in PBS again, dipped in diamidinophenylindole (DAPI, 0.5 µg/ml), and washed in PBS for a further 5 min. For double-labeling experiments, each of the two primary and two secondary antibodies was applied sequentially, with washing in between applications. Citifluor was applied to the slides, and the coverslips were sealed. Slides were visualized by using a Deltavision cooled charge-coupled device imaging system (Applied Precision Inc.). Images from the fluorescence microscope were collected and analyzed with Softworx and were prepared for publication with Adobe Photoshop.

Nucleotide sequence accession numbers. The nucleotide sequences reported in this study are available in the GenBank database under accession numbers AJ430086 to AJ430089.


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Variations in the sequences of the PfRH family in different P. falciparum lines. A sequence coding for an additional member of the PfRH family was identified on chromosome 4 in the P. falciparum genome sequence database (chr4_P19325, as of 21 December 2001). Following the removal of a single intron, this sequence potentially codes for a 358-kDa type I membrane protein, PfRH1. It has sequence similarity to the other members of the superfamily and contains the motifs within the previously defined homology region that distinguish it as a member of the family (17, 22, 49) (Fig. 1A). Figure 1B shows the alignment of this region in PfRH1, PfRH2a, PfRH2b, and PfRH3; PvRBP1 and PvRBP2; and E8 and E3, members of the Py235 family. However, the sequence contained a reading frame shift (at about amino acids 2764 to 2766 of the predicted sequence for PfRH1) in the database contig. To determine whether this sequence was correct or was a sequencing artifact, primers spanning this region were used to PCR amplify the sequence from 3D7 DNA. The PCR was performed with the proofreading polymerase Pfx. The sequences of three independent PCR products were identical and demonstrated an open reading frame across this region. This sequence result was confirmed by using DNA derived from three 3D7 lines: the current batch growing at the National Institute for Medical Research; a batch from 1998 derived from a recloned parasite obtained from The Weatherall Institute for Molecular Medicine, Oxford, United Kingdom; and a batch from The Walter and Eliza Hall Institute, Melbourne, Victoria, Australia. All three 3D7 stocks were identical at the polymorphic loci MSP1 and MSP2. Both FCB1 and T996 parasites had the same open reading frame across this region of PfRH1. There were, however, differences in the nucleotide sequence coding for a run of His-Asn and Gln-Asn (HN and QN) repeats (Fig. 1C).



View larger version (68K):
[in this window]
[in a new window]
  		FIG. 1. PfRH1 is a member of the PfRH protein family. (A) Diagrammatic representation of PfRH1, PfRH2a, and PfRH2b. One centimeter represents 250 amino acids. hr, homology region (hatched boxes); ss, signal sequence (light grey boxes); tm, transmembrane region (black box). In PfRH2a and PfRH2b, the boxes with wavy grey lines represent the degenerate repeat region, and the boxes with dots and checks represent the unique parts of PfRH2a and PfRH2b, respectively. Constructs used to raise GST fusion proteins are marked RH1.1, RH1.2, RH2.HR, RH2a.1, and RH2b.1. (B) Alignment of the homology region of PfRH1 with those previously described. Sequences were aligned by using ClustalX (50) and the following regions of the proteins (GenBank accession numbers): E8 (U36927), 1669 to 1837; E3 (L27838), 1175 to 1343 (incomplete sequence); PvRBP1 (M88097), 1717 to 1885; PvRBP2 (AF184623), 1680 to 1848; PfRH1, 1898 to 2072; PfRH2 (AF312916 and AF312917), 1688 to 1857; and PfRH3 (predicted protein correcting the frameshifts in AF324831), 1751 to 1920. Shading of conserved (black) and semiconserved (grey) residues was done by using BioEdit (18) with the Blosum 62 matrix. (C) Alignment of portions of the predicted protein sequences from region PfRH1.2, starting at amino acid 2840, in 3D7, T996, and FCB1.

 
Sequence variations in PfRH2a and PfRH2b between different parasite lines were previously described for a region of degenerate repeats near the 3' end of the gene (44, 52). In addition, a parasite line lacking the PfRH2b gene was also described (52). The P. falciparum 3D7, FCB1, and T996 lines differ across the region of degenerate repeats in the sequences of both PfRH2a and PfRH2b (Fig. 2A). In addition, PfRH2b in T996 has a 585-bp deletion in the 3' end downstream of the repeats but upstream of the region coding for the transmembrane domain (Fig. 2). A polymorphism in the sequence of PfRH3 was previously described (49).



View larger version (48K):
[in this window]
[in a new window]
  		FIG. 2. PfRH2b contains a large deletion in T996 parasites. (A) PCR across the repeat regions of PfRH2a (left) and PfRH2b (middle) demonstrating the size polymorphisms in 3D7 (lanes 2), T996 (lanes 3), and FCB1 (lanes 4). Lane 1, 1-kb marker (Invitrogen Life Technologies). The large size polymorphism in PfRH2b (right) seen with T996 is due to a 585-bp deletion in fragment PfRH2b.1. Lane 1, 1-kb marker; lane 2, 3D7; lane 3, T996. (B) Alignment of region PfRH2b.1 in 3D7 and T996, showing the 195-amino-acid deletion in T996.

 
3D7 and T996 parasites transcribe all the members of the family, while FCB1 does not transcribe PfRH2a or PfRH2b. To confirm that PfRH1 was transcribed and to identify the 5' end of the gene, 5' RACE was carried out with RNA prepared from 3D7 schizonts. Sequencing of the RACE products revealed that a 98-bp intron is removed in the mRNA, after a 55-bp first exon. This is the same basic gene structure as that identified in all other members of the superfamily. The first exon codes for a hydrophobic region that is predicted by iPSORT to contribute to an N-terminal signal sequence, with the cleavage site between N30 and E31 (http://www.HypothesisCreator.net/iPSORT).

To determine the precise timing of transcription of the PfRH gene family, RNA was isolated from tightly synchronized cultures of 3D7 parasites at 4-h intervals. Northern analysis of RNA at these time points revealed that the transcription of all four genes (PfRH1, PfRH2a, PfRH2b, and PfRH3) is tightly regulated, with the greatest message abundance in late schizonts, just prior to merozoite release (Fig. 3). Probing the Northern blot with the constitutively expressed sequence C-341 (4) demonstrated that although the lanes for the later stages were relatively overloaded compared to those for the ring stages, there were few loading differences in the samples from 20 h onward. The lack of transcription of the PfRH genes in ring stages was confirmed by using an additional Northern blot with equal amounts of ring-, trophozoite-, and schizont-stage RNA (data not shown). Hence, the signal intensities obtained with the PfRH probes are not accounted for by the presence of different amounts of total RNA.



View larger version (66K):
[in this window]
[in a new window]
  		FIG. 3. Transcription of the PfRH gene family is stage specific. (A) Giemsa-stained smears of 3D7 parasites harvested during their developmental cycle for RNA analysis. Each smear is labeled with the time of harvesting in hours after invasion. (B) Northern analysis of RNA from 3D7 parasites throughout their developmental cycle. Tightly synchronized 3D7 parasites were harvested at 4-h intervals over a 48-h period, and RNA was extracted at each time point and analyzed by hybridization of a Northern blot. Each lane is labeled with the time of harvesting in hours after invasion. The blot was hybridized with probes for PfRH1 (region PfRH1.1), PfRH2a (region PfRH2a.1), PfRH2b (region PfRH2b.1), PfRH3 (homology region) (49), and C-341 (a constitutively expressed sequence) (4). Each probe hybridized to a different transcript which was larger than the highest-molecular-mass marker (9.49 kb), with the exception of C-341, which was 2.5 kb.

 
Late schizonts (40 h onward postinvasion) were collected from cultures of 3D7, T996, and FCB1. Figure 4A shows Giemsa-stained smears of each of these cultures, confirming that all three are at the same stage. A Northern blot of RNA from these parasites was probed with each of PfRH1 to PfRH3 and with msp7, a gene which has been shown to be transcribed in schizonts (38) (Fig. 4B). The message for PfRH1 is much more abundant in FCB1 than in 3D7 or T996 parasites. In contrast to the 3D7 and T996 lines, the FCB1 line makes no message for either PfRH2a or PfRH2b. The signal obtained with the probe for PfRH2b in T996 is lower than that obtained in 3D7, but for this gene the relative amounts of message cannot be determined, as the probe spanned the region of PfRH2b that contains the 585-bp deletion in T996. The 3D7 line makes less transcript for the pseudogene PfRH3 than the other two parasite lines. Approximately the same amounts of total RNA were loaded in the lanes, as demonstrated by probing the filter with msp7 and another rhoptry protein gene (data not shown).



View larger version (51K):
[in this window]
[in a new window]
  		FIG. 4. Transcription of the PfRH gene family varies between parasite lines. (A) Giemsa-stained smears of late 3D7, FCB1, and T996 schizonts harvested for RNA analysis. (B) Northern analysis of RNA from late 3D7 (lanes 3), FCB1 (lanes F), and T996 (lanes T) schizonts. RNA on four identical blots was hybridized to probes for PfRH1 (region PfRH1.1), PfRH2a (region PfRH2a.1), PfRH2b (region PfRH2b.1), and PfRH3 (homology region). The blots were stripped and probed with msp7 to check for equal loading (38). All probes were derived from 3D7 DNA. The probe for PfRH2b spans the region of the gene in T996 which has undergone a 585-bp deletion; hence, the relative amounts of PfRH2b mRNA in 3D7 and T996 cannot be directly compared. Size markers are in kilobases.

 
The expression of PfRH1 differs in 3D7 and T996 compared to FCB1 parasites. Polyclonal antisera were raised in mice and rabbits to GST fusion proteins containing different regions of PfRH1, PfRH2a, and PfRH2b (Fig. 1A). The specificity of the antibodies was confirmed by immunoprecipitating in vitro-translated proteins derived either from the same region of the gene or from control sequences as previously described (49) (data not shown).

Antiserum RH1.1 immunoprecipitated high-molecular-mass proteins from metabolically labeled late schizonts. In FCB1 schizonts, a predominant band of about 195 kDa was seen, along with a high-molecular-mass band (>240 kDa) (Fig. 5A). Proteins of similar sizes were also immunoprecipitated from 3D7 and T996 schizonts (Fig. 5A and data not shown), although they were much less abundant in lysates of these parasite lines.



View larger version (58K):
[in this window]
[in a new window]
  		FIG. 5. Expression of PfRH1, PfRH2a, and PfRH2b in 307 and FCB1 schizonts. (A) Immunoprecipitation of metabolically labeled FCB1 and 3D7 schizont extracts with antibodies to PfRH1, PfRH2a, and PfRH2b. Proteins were immunoprecipitated from late-schizont lysates (extracted with SDS and DOC) by using normal mouse serum (lanes N), antiserum RH1.1 (lanes 1), antiserum RH2a.1 (lanes 2a), antiserum RH2b.1 (lanes 2b), or antiserum RH2.HR (lane 2a/b) and then run on 5% polyacrylamide gels. Size markers are shown in kilodaltons. The proteins immunoprecipitated with antiserum RH1.1 are marked with arrows on the left side of each panel, and those immunoprecipitated with antisera RH2a and RH2b are marked with arrows on the right side. The same bands were present when parasites were extracted with NP-40. (B) Immunoprecipitation of metabolically labeled 3D7 schizonts treated or not treated with BFA. 3D7 schizonts (40 to 42 h postinvasion) were treated with BFA (+) or methanol (control) (-) for 1 h and then metabolically labeled in the continuing presence of BFA or methanol. Proteins were immunoprecipitated from parasite lysates (extracted with SDS and DOC) by using antiserum RH1.1 (lanes 1), antiserum RH2a.1 (lanes 2a), antiserum RH2b.1 (lanes 2b), or antiserum RH2.HR (lanes 2a/b) and then run on 3 to 8% NuPAGE Tris-acetate gels. Size markers are shown in kilodaltons.

 
The predicted molecular mass of PfRH1 is 358 kDa, much larger than that of the most predominant protein immunoprecipitated with antiserum RH1.1. However, the 195-kDa protein was shown to be derived from the high-molecular-mass protein following treatment of 3D7 and FCB1 schizont cultures with BFA. BFA reversibly blocks protein translocation from the endoplasmic reticulum (ER) to the Golgi complex. Biosynthetic labeling of late-schizont cultures in the presence of BFA led to an accumulation of the high-molecular-mass band in both 3D7 (Fig. 5B) and FCB1 (data not shown) schizonts. The same high-molecular-mass band was seen in BFA-treated 3D7 parasites after immunoprecipitation with antiserum RH1.2 (data not shown). This process was fully reversible following BFA removal before labeling. These results demonstrated that the larger band is full-length PfRH1 and that PfRH1 is processed by proteolysis after trafficking through the ER. Immunoblotting (see below) confirmed that the smaller band in FCB1 was the processed product of PfRH1. We were unable to detect any soluble PfRH1 in culture supernatants from 3D7, T996, or FCB1 parasites.

Antiserum RH2.HR was raised to a region common to both PfRH2a and PfRH2b and hence should recognize both proteins. The antiserum recognized a series of high-molecular-mass bands in lysates of 3D7 and T996 but not FCB1 schizonts (Fig. 5A and data not shown). The protein-specific antisera RH2a.1 and RH2b.1 each recognized a subset of these bands (Fig. 5A). Again, the minor high-molecular-mass bands were shown to be precursors of the smaller proteins by radiolabeling the cultures in the presence of BFA (Fig. 5B). These results also suggested that the processing of PfRH2a and PfRH2b occurs at the N-terminal end of these proteins, in a fashion similar to the processing of Py235 (34), because antisera RH2a.1 and RH2b.1 were raised to constructs derived from the C-terminal end of the proteins.

Antisera to PfRH1, PfRH2a, and PfRH2b were used to probe Western blots of parasite extracts (both late schizonts and purified merozoites). Antiserum RH1.1 reacted with an ~195-kDa band in FCB1 schizonts and merozoites and with a minor high-molecular-mass band corresponding in size to the proteins immunoprecipitated from the metabolically labeled cultures. In contrast, no obvious bands of reactivity were seen with antiserum RH1.1 when 3D7 or T996 schizonts or merozoites were probed (Fig. 6). The most likely explanation for the different results obtained with the Western blotting and immunoprecipitation methods is that the PfRH1 protein was present below the level of detection of Western blotting in 3D7 and T996 but was detected with the more sensitive immunoprecipitation method, particularly in the presence of BFA.



View larger version (37K):
[in this window]
[in a new window]
  		FIG. 6. Immunoblots of parasite extracts probed with antisera to PfRH1, PfRH2a, and PfRH2b. Late T996 schizonts (lanes Ts), 3D7 schizonts (lanes 3s), and FCB1 schizonts (lanes Fs) and purified merozoites from 3D7 (lanes 3m) and FCB1 (lanes Fm) were lysed directly into NuPAGE or SDS-PAGE loading buffer and run on 3 to 8% NuPAGE Tris-acetate gels (left and middle panels) or 5% polyacrylamide gels (right panel). Lanes U, uninfected erythrocytes. Gels were blotted onto nitrocellulose membranes and probed with polyclonal mouse antisera RH1.1, RH2a.1, and RH2b.1; detection was done with enhanced chemiluminescence. Size markers are shown in kilodaltons.

 
Antiserum RH2.HR cross-reacted very strongly with spectrin from uninfected red blood cells and gave a high nonspecific background with purified merozoites on Western blots. However, the two specific antisera to PfRH2a and PfRH2b, RH2a.1 and RH2b.1, reacted with high-molecular-mass bands in lysates of both 3D7 and T996 but not of FCB1 (Fig. 6). The proteins recognized by antiserum RH2b.1 (and, to a lesser extent, RH2a.1) were larger in 3D7 than in T996, in agreement with the differences in the sizes of the genes in the two parasite lines. Interestingly, for both PfRH1 in FCB1 and PfRH2a and PfRH2b in 3D7, the high-molecular-mass forms of the proteins were detected in merozoites, suggesting that this stage of the parasite was actively making these proteins. There was almost no schizont contamination of the merozoite preparations, discounting the possibility that the high-molecular-mass forms of the proteins were carried over from these stages.

Despite demonstrating the presence of PfRH1 in 3D7 and T996 parasites by immunoprecipitation, we did not detect any staining when antibodies to this protein were used in IFAs with 3D7 or T996 schizonts (Fig. 7). In contrast, strong apical staining was seen with both antiserum RH1.1 and antiserum RH1.2 for FCB1 parasites. Only late schizonts or free merozoites were stained with these antisera. The staining pattern with free merozoites suggested that PfRH1 moves from the apical organelles in the maturing schizont to the apical surface of the merozoite. In some merozoites, staining was seen around the anterior half of the merozoite surface (Fig. 7).



View larger version (29K):
[in this window]
[in a new window]
  		FIG. 7. Single-staining IFA of 3D7, T996, and FCB1 parasites. Primary antibodies were polyclonal mouse antisera RH1.1, RH1.2, RH2a.1, and RH2b.1. Secondary antibodies were FITC-conjugated anti-mouse immunoglobulin G (Sigma). The parasite nuclei are stained with DAPI. Scale bar, 10 µm.

 
Antibodies to PfRH2 were also used in IFAs. Due to its strong cross-reaction with spectrin, neither preabsorbing antiserum RH2.HR with uninfected red blood cells nor affinity selecting it on recombinant protein PfRH2.HR was able to reduce the background with this antiserum in IFAs. However, each of the antisera RH2a.1 and RH2b.1 gave a punctate pattern of staining with late schizonts, sometimes giving the characteristic double dot typical of a location in the rhoptries (Fig. 7). In free merozoites, apical staining was seen (Fig. 8). As expected, FCB1 parasites were not stained with these antisera.



View larger version (21K):
[in this window]
[in a new window]
  		FIG. 8. Double-staining IFA of FCB1 and 3D7 parasites. (A and B) FCB1 parasites. (C to H) 3D7 parasites. All panels show late schizonts, except for panels F and H, which show released merozoites. The following primary antibodies were used: mouse polyclonal antisera RH1.1, RH2a.1, and RH2b.1; rabbit polyclonal antiserum RH2a.1 and antiserum to RhopH2 (a rhoptry protein); rat polyclonal antiserum to EBA-175 (a microneme protein); and rat MAb 4G2dc1 to AMA-1 (thought to be located in the rhoptries). Parasite nuclei are stained with DAPI (blue). For each panel, the FITC-conjugated sec-ondary antibodies (green) are to mouse polyclonal sera, and the TRITC-conjugated secondary antibodies (red) are to rabbit polyclonal sera, with the following exceptions. (E and F) Rabbit antiserum RH2a.1 was labeled with FITC-conjugated anti-rabbit immunoglobulin G (IgG) (Sigma), and rat MAb 4G2dc1 was labeled with Texas red-conjugated anti-rat IgG (Sigma). (H) Rabbit antiserum RH2a.1 was labeled as described above, and rat antiserum to EBA-175 was labeled with Texas red-conjugated anti-rat IgG. In the merged images, areas of overlap between the red and the green signals are shown in yellow. Scale bar, 10 µm.

 
Double staining and fluorescence microscopy were used to try to establish whether the PfRH proteins were located in the rhoptries of P. falciparum. Antisera to a known rhoptry protein, RhopH2, to AMA-1 (thought to be located in the rhoptries), and to micronemal protein EBA-175 were used in conjunction with antisera to PfRH1 and PfRH2 in double-staining IFAs. In late FCB1 schizonts, there was a large degree of overlap between the staining obtained not only with antisera to PfRH1 and RhopH2 but also with antisera to PfRH1 and EBA-175, particularly in free merozoites (Fig. 8). The colocalization of PfRH1 and RhopH2 was confirmed by using confocal microscopy with sequential image acquisition (data not shown). On the other hand, in late 3D7 schizonts, both PfRH2a and PfRH2b colocalized with RhopH2 but not with EBA-175. In free merozoites, the distributions of PfRH2a and PfRH2b were closer to the distribution of EBA-175 (Fig. 8). Surprisingly, in the schizont stages, the distributions of PfRH2a and AMA-1 were not as close as expected from the results obtained with RhopH2, although this discrepancy could reflect the controversy over the location of AMA-1 (6). In both schizonts and merozoites, colocalization of PfRH2a and PfRH2b was seen.


   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In this report, we demonstrate that different laboratory lines of P. falciparum vary in their expression of members of a protein family implicated in parasite invasion. The three laboratory lines, 3D7, FCB1, and T996, differ in the sequences and levels of transcription of different members of the PfRH family and in the amounts and locations of the PfRH proteins. FCB1 expresses PfRH1 at the apical end of merozoites within late schizonts but does not express either PfRH2a or PfRH2b. In contrast, 3D7 and T996 make PfRH1, but the protein is not seen in the apical organelles by IFAs. 3D7 and T996 parasites express both PfRH2a and PfRH2b, and both proteins appear to be initially located in the rhoptries. In T996, the large deletion toward the C terminus of PfRH2b does not affect the location of this protein.

The resolution of the images produced by IFAs with a fluorescence microscope was insufficient for a definitive assignment of these proteins to specific organelles. Even sequential image acquisition with confocal microscopy did not provide an absolutely clear result, because the size of the rhoptry and microneme organelles and the space between them are close to the resolution of the microscope. Nevertheless, the data suggest that in late schizonts, the PfRH2 proteins are located in the rhoptries, but at schizont rupture, the proteins move apically to the tip of free merozoites. These suggestions are in agreement with previously published work on PfRH2 (44, 52). The data for PfRH1 are less clear, but it appears that this protein also moves from apical organelles, relocating to the merozoite apex and around the surface, distributing backward from the tip. There is a precedent for this type of capping in Plasmodium merozoites: a processed form of AMA-1 has been shown to cap backward over the merozoite surface during invasion (32). It has been suggested that this process may occur by interaction with the actin-myosin motor of the parasite (20), as has been described for some microneme proteins in other apicomplexans (8, 10). As none of the three parasite lines examined expressed all three proteins at the apical end of the merozoite, it was not possible from these experiments to determine whether PfRH1, PfRH2a, and PfRH2b are in the same compartment. Definitive experiments to localize these proteins to cellular compartments will require a combination of subcellular fractionation, electron microscopy, and more molecular markers for specific compartments (6).

The contig on which we found PfRH1 contains a frameshift in the gene sequence, and it has been suggested that 3D7 makes a truncated version of PfRH1 (45). We sequenced several PCR products covering this region from 3D7 parasites cultured at different times and recently originating from different laboratories, showing conclusively that there is no frameshift in the 3D7 parasites used in the experiments described in this study. The 3D7 line makes both the full-length transcript and the full-length PfRH1 protein. However, the relatively low level of PfRH1 immunoprecipitated from 3D7 and T996 schizonts and our inability to detect the protein by Western blotting and IFA analysis suggest that the protein is made in a small quantity and/or rapidly turned over. Either or both of these two explanations would fit with these data. For example, a very small amount of protein may be made and correctly located at the apical end of the parasite but be below the level of detection of an IFA. Furthermore, the protein may be rapidly degraded after passage beyond the ER and may or may not be transported to the apical organelles. We favor the explanation of rapid turnover, because more PfRH1 was immunoprecipitated from BFA-treated 3D7 parasites than from the untreated control parasites. However, no antigen was detected by antisera to PfRH1 in IFAs with BFA-treated 3D7 parasites, suggesting that for detection by IFAs, this protein must be locally concentrated.

It is interesting that FCB1, which does not make PfRH2a and PfRH2b, may compensate by making increased amounts of PfRH1 transcript and PfRH1 protein. However, this may be only part of the story. During preparation of this manuscript, Rayner and coworkers described P. falciparum normocyte binding protein 1 (PfNBP1) (45). PfNBP1 is the same protein as that described here as PfRH1. The reported location of PfNBP1 matches that of PfRH1. Interestingly, Rayner et al. (45) demonstrated apical expression of PfRH1 and either PfRH2a or PfRH2b or both in one parasite line, FVO. As the PfRH2-specific antibody used recognized both PfRH2a and PfRH2b, it is possible, but not certain, that FVO parasites express all three proteins at the apex of the merozoite. Rayner et al. (45) suggested that PfNBP1 and PfRH2b form a complex, based on the presence in the immunoprecipitate obtained with antibodies to PfNBP1 of an additional high-molecular-mass doublet which is similar in size to that recognized by antibodies to PfRH2b. However, PfNBP1 did not appear to be present in the reciprocal immunoprecipitation. Our results obtained with parasites treated with BFA suggest a more likely explanation—that the doublet is actually a processed product of PfNBP1 or PfRH1. In the 3D7 and FCB1 lines, a complex between PfRH1 and PfRH2 is unlikely to be seen, because 3D7 expresses only a low level of PfRH1 which cannot be detected at the end of the merozoite and FCB1 does not express PfRH2a or PfRH2b.

The three PfRH proteins described thus far have been shown to have a role in erythrocyte invasion (44, 45, 52). PfNBP1 or PfRH1 binds to a trypsin-resistant uncharacterized erythrocyte ligand, and antibodies to PfRH1, PfRH2a, and PfRH2b have been shown to inhibit invasion. No erythrocyte binding activity has been demonstrated for PfRH2. However, not all proteins involved in erythrocyte invasion will necessarily bind to the erythrocyte surface. Other possible roles include intracellular signaling, interaction with the actin-myosin motor of the parasite, or restructuring of the host cell cytoskeleton (6, 42). These processes are well recognized in other invasive microorganisms (reviewed in references 14, 28, and 47).

It is clear that some lines of P. falciparum maintained in vitro have mutant phenotypes of the RH protein family (if an apical location of PfRH1 and PfRH2 is the wild type), and these parasites do not require all three proteins to invade at least some erythrocytes. It has yet to be shown definitively that all three proteins can be expressed apically in the same merozoite. This phenotypic diversity highlights a potential difficulty in interpreting the results of experiments designed to disrupt members of this family. The background phenotype of the parasite must be characterized, even in parasites that make transcripts for all family members.

Diversity in the RH protein family may allow the parasite to invade erythrocytes with structurally diverse receptors. This variability is at the levels of sequence variation and expression of the proteins. P. vivax parasites are able to invade only reticulocytes and require selection of the correct cells by the PvRBP (16). Moreover, invasion is dependent on an interaction between the erythrocyte Duffy blood group antigen and the parasite Duffy binding protein (a member of the EBP family) (2, 30). In contrast, multiple invasion pathways are available for P. falciparum parasites (9, 13, 36, 37, 46). The apparent redundancy in the PfRH protein family may allow the parasite to use alternative invasion pathways. An added level of complexity is the presence of several EBPs in P. falciparum (1, 29, 31, 40, 51, 53). How the PfRH proteins interact with each other and with other proteins known to be involved in invasion is a crucial question. As more merozoite proteins are identified from the P. falciparum genome sequencing project and the related proteomics project (3) (http://www.ebi.ac.uk/parasites/proteomes.html), it is certain that additional proteins involved in invasion will be identified. For example, there is at least one other P. falciparum sequence that shares some similarity with PfRH family sequences (PfRH4) (21; unpublished data). It will be important to determine whether there is a requirement for all the PfRH proteins to be functional in parasites isolated from natural infections or whether there is a level of redundancy within the family, as shown in laboratory lines.


   ACKNOWLEDGMENTS
 
We thank Sola Ogun and Irene Ling for invaluable help. We also thank the following people for providing various reagents: 3D7 parasites were a gift from Chris Newbold, The Weatherall Institute for Molecular Medicine, Oxford, United Kingdom, and from Alan Cowman, The Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; rabbit and rat antisera to EBA-175 were gifts from John Adams, University of Notre Dame, Notre Dame, Ind.; and MAb 4G2dc1 was a gift from Alan Thomas, Biomedical Primate Research Centre, Rijswijk, The Netherlands.

The sequencing of P. falciparum chromosome 4 was accomplished as part of the Malaria Genome Project with support from The Wellcome Trust. This work was supported in part by EU grant IC18 CT98 0369 and in part by the Medical Research Council.


   FOOTNOTES
 
* Corresponding author. Mailing address: Division of Parasitology, National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom. Phone: 44 208 959 3666. Fax: 44 208 913 8593. E-mail: htaylor{at}nimr.mrc.ac.uk. Back

Editor: J. M. Mansfield


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
1. Adams, J. H., P. L. Blair, O. Kaneko, and D. S. Peterson. 2001. An expanding ebl family of Plasmodium falciparum. Trends Parasitol. 17:297-299.J. D.J. K.[CrossRef][Medline]
2. Barnwell, J. W., M. E. Nichols, and P. Rubinstein. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 169:1795-1802.[Abstract/Free Full Text]
3. Barrett, J., J. R. Jefferies, and P. M. Brophy. 2000. Parasite proteomics. Parasitol. Today 16:400-403.[CrossRef][Medline]
4. Ben Mamoun, C., I. Y. Gluzman, C. Hott, S. K. MacMillan, A. S. Amarakone, D. L. Anderson, J. M. Carlton, J. B. Dame, D. Chakrabarti, R. K. Martin, B. H. Brownstein, and D. E. Goldberg. 2001. Co-ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis. Mol. Microbiol. 39:26-36.[CrossRef][Medline]
5. Blackman, M. J. 1994. Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. Methods Cell Biol. 45:213-220.
6. Blackman, M. J., and L. H. Bannister. 2001. Apical organelles of Apicomplexa: biology and isolation by subcellular fractionation. Mol. Biochem. Parasitol 117:11-25.[CrossRef][Medline]
7. Blackman, M. J., and A. A. Holder. 1992. Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. Mol. Biochem. Parasitol 50:307-315.[CrossRef][Medline]
8. Bumstead, J., and F. Tomley. 2000. Induction of secretion and surface capping of microneme proteins in Eimeria tenella. Mol. Biochem. Parasitol. 110:311-321.[CrossRef][Medline]
9. Camus, D., and T. J. Hadley. 1985. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230:553-556.[Abstract/Free Full Text]
10. Carruthers, V. B., and L. D. Sibley. 1999. Mobilization of intracellular calcium stimulates microneme discharge in Toxoplasma gondii. Mol. Microbiol. 31:421-428.[CrossRef][Medline]
11. Chitnis, C. E. 2001. Molecular insights into receptors used by malaria parasites for erythrocyte invasion. Curr. Opin. Hematol. 8:85-91.[CrossRef][Medline]
12. Cowman, A. F., D. L. Baldi, J. Healer, K. E. Mills, R. A. O'Donnell, M. B. Reed, T. Triglia, M. E. Wickham, and B. S. Crabb. 2000. Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells. FEBS Lett. 476:84-88.[CrossRef][Medline]
13. Dolan, S. A., J. L. Proctor, D. W. Alling, Y. Okubo, T. E. Wellems, and L. H. Miller. 1994. Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol. Biochem. Parasitol. 64:55-63.[CrossRef][Medline]
14. Dramsi, S., and P. Cossart. 1998. Intracellular pathogens and the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 14:137-166.[CrossRef][Medline]
15. Fraser, T. S., S. H. Kappe, D. L. Narum, K. M. VanBuskirk, and J. H. Adams. 2001. Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells. Mol. Biochem. Parasitol. 117:49-59.[CrossRef][Medline]
16. Galinski, M. R., C. C. Medina, P. Ingravallo, and J. W. Barnwell. 1992. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 69:1213-1226.[CrossRef][Medline]
17. Galinski, M. R., M. Xu, and J. W. Barnwell. 2000. Plasmodium vivax reticulocyte binding protein-2 (PvRBP-2) shares structural features with PvRBP-1 and the Plasmodium yoelii 235 kDa rhoptry protein family. Mol. Biochem. Parasitol. 108:257-262.[CrossRef][Medline]
18. Hall, T. A. 1999. BioEdit: a user friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
19. Holder, A. A., R. R. Freeman, S. Uni, and M. Aikawa. 1985. Isolation of a Plasmodium falciparum rhoptry protein. Mol. Biochem. Parasitol. 14:293-303.[CrossRef][Medline]
20. Howell, S. A., C. Withers-Martinez, C. H. Kocken, A. W. Thomas, and M. J. Blackman. 2001. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J. Biol. Chem. 276:31311-31320.[Abstract/Free Full Text]
21. Kaneko, O., J. Mu, T. Tsuboi, X. Su, and M. Torii. 2002. Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol. Biochem. Parasitol. 121:275-278.[CrossRef][Medline]
22. Keen, J. K., K. A. Sinha, K. N. Brown, and A. A. Holder. 1994. A gene coding for a high-molecular mass rhoptry protein of Plasmodium yoelii. Mol. Biochem. Parasitol. 65:171-177.[CrossRef][Medline]
23. Kocken, C. H., A. M. van der Wel, M. A. Dubbeld, D. L. Narum, F. M. van de Rijke, G. J. van Gemert, X. van der Linde, L. H. Bannister, C. Janse, A. P. Waters, and A. W. Thomas. 1998. Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J. Biol. Chem. 273:15119-15124.[Abstract/Free Full Text]
24. Kyes, S., R. Harding, G. Black, A. Craig, N. Peshu, C. Newbold, and K. Marsh. 1997. Limited spatial clustering of individual Plasmodium falciparum alleles in field isolates from coastal Kenya. Am. J. Trop. Med. Hyg. 57:205-215.
25. Kyes, S., R. Pinches, and C. Newbold. 2000. A simple RNA analysis method shows var and rif multigene family expression patterns in Plasmodium falciparum. Mol. Biochem. Parasitol. 105:311-315.[CrossRef][Medline]
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.[CrossRef][Medline]
27. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.[CrossRef][Medline]
28. Lauwaet, T., M. J. Oliveira, M. Mareel, and A. Leroy. 2000. Molecular mechanisms of invasion by cancer cells, leukocytes and microorganisms. Microbes Infect. 2:923-931.[CrossRef][Medline]
29. Mayer, D. C., O. Kaneko, D. E. Hudson-Taylor, M. E. Reid, and L. H. Miller. 2001. Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175. Proc. Natl. Acad. Sci. USA 98:5222-5227.[Abstract/Free Full Text]
30. Miller, L. H., S. J. Mason, D. F. Clyde, and M. H. McGinniss. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-304.[Abstract]
31. Narum, D. L., S. R. Fuhrmann, T. Luu, and B. K. Sim. 2002. A novel Plasmodium falciparum erythrocyte binding protein-2 (EBP2/BAEBL) involved in erythrocyte receptor binding. Mol. Biochem. Parasitol. 119:159-168.[CrossRef][Medline]
32. Narum, D. L., and A. W. Thomas. 1994. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 67:59-68.[CrossRef][Medline]
33. Ogun, S. A., and A. A. Holder. 1996. A high molecular mass Plasmodium yoelii rhoptry protein binds to erythrocytes. Mol. Biochem. Parasitol. 76:321-324.[CrossRef][Medline]
34. Ogun, S. A., and A. A. Holder. 1994. Plasmodium yoelii: brefeldin A-sensitive processing of proteins targeted to the rhoptries. Exp. Parasitol. 79:270-278.[CrossRef][Medline]
35. Ogun, S. A., T. J. Scott-Finnigan, D. L. Narum, and A. A. Holder. 2000. Plasmodium yoelii: effects of red blood cell modification and antibodies on the binding characteristics of the 235-kDa rhoptry protein. Exp. Parasitol. 95:187-195.[CrossRef][Medline]
36. Okoyeh, J. N., C. R. Pillai, and C. E. Chitnis. 1999. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect. Immun. 67:5784-5791.
37. Orlandi, P. A., F. W. Klotz, and J. D. Haynes. 1992. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A. J. Cell Biol. 116:901-909.[Abstract/Free Full Text]
38. Pachebat, J. A., I. T. Ling, M. Grainger, C. Trucco, S. Howell, D. Fernandez-Reyes, R. Gunaratne, and A. A. Holder. 2001. The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. Mol. Biochem. Parasitol. 117:83-89.[CrossRef][Medline]
39. Pasvol, G., R. J. Wilson, M. E. Smalley, and J. Brown. 1978. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann. Trop. Med. Parasitol. 72:87-88.[Medline]
40. Peterson, D. S., and T. E. Wellems. 2000. EBL-1, a putative erythrocyte binding protein of Plasmodium falciparum, maps within a favored linkage group in two genetic crosses. Mol. Biochem. Parasitol. 105:105-113.[CrossRef][Medline]
41. Peterson, M. G., V. M. Marshall, J. A. Smythe, P. E. Crewther, A. Lew, A. Silva, R. F. Anders, and D. J. Kemp. 1989. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol. Cell. Biol. 9:3151-3154.[Abstract/Free Full Text]
42. Pinder, J., R. Fowler, L. Bannister, A. Dluzewski, and G. H. Mitchell. 2000. Motile systems in malaria merozoites: how is the red blood cell invaded? Parasitol. Today 16:240-245.[CrossRef][Medline]
43. Preiser, P. R., M. Kaviratne, S. Khan, L. H. Bannister, and W. Jarra. 2000. Apical organelles of malaria merozoites: host cell selection, invasion, host immunity and immune evasion. Microbes Infect. 2:1-17.
44. Rayner, J. C., M. R. Galinski, P. Ingravallo, and J. W. Barnwell. 2000. Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc. Natl. Acad. Sci. USA 97:9648-9653.[Abstract/Free Full Text]
45. Rayner, J. C., E. Vargas-Serrato, C. S. Huber, M. R. Galinski, and J. W. Barnwell. 2001. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J. Exp. Med. 194:1571-1581.[Abstract/Free Full Text]
46. Sim, B. K., C. E. Chitnis, K. Wasniowska, T. J. Hadley, and L. H. Miller. 1994. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264:1941-1944.[Abstract/Free Full Text]
47. Soldati, D., J. F. Dubremetz, and M. Lebrun. 2001. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int. J. Parasitol. 31:1293-1302.[CrossRef][Medline]
48. Staalsoe, T., H. A. Giha, D. Dodoo, T. G. Theander, and L. Hviid. 1999. Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. Cytometry 35:329-336.[CrossRef][Medline]
49. Taylor, H. M., T. Triglia, J. Thompson, M. Sajid, R. Fowler, M. E. Wickham, A. F. Cowman, and A. A. Holder. 2001. Plasmodium falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii adhesive proteins, which is transcribed but not translated. Infect. Immun. 69:3635-3645.[Abstract/Free Full Text]
50. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The Clustal_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
51. Thompson, J. K., T. Triglia, M. B. Reed, and A. F. Cowman. 2001. A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol. Microbiol. 41:47-58.[CrossRef][Medline]
52. Triglia, T., J. Thompson, S. R. Caruana, M. Delorenzi, T. Speed, and A. F. Cowman. 2001. Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax. Infect. Immun. 69:1084-1092.[Abstract/Free Full Text]
53. Triglia, T., J. K. Thompson, and A. F. Cowman. 2001. An EBA175 homologue which is transcribed but not translated in erythrocytic stages of Plasmodium falciparum. Mol. Biochem. Parasitol. 116:55-63.[CrossRef][Medline]

Infection and Immunity, October 2002, p. 5779-5789, Vol. 70, No. 10
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.10.5779-5789.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, H. M.
Right arrow Articles by Holder, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, H. M.
Right arrow Articles by Holder, A. A.